PURPOSE: We hypothesized that sustained delivery of vascular endothelial growth factor (VEGF) using a polymer [85:15 poly(lactide-co-glycolide) (PLG)] would enhance angiogenesis and improve perfusion of ischemic tissue. METHODS: C57BL/6J mice (n = 20/group) underwent unilateral hind limb ischemia surgery and were randomized to groups of no scaffold implantation (0-Implant), unloaded scaffold implantation (Empty-PLG), or implantation of scaffolds incorporating 3 microg of VEGF165 (PLG-VEGF). Endpoints included laser Doppler perfusion imaging (LDPI, ischemic/nonischemic limb, %), local vessel counts, immunohistochemistry for CD31, and alpha-smooth muscle actin. In vitro release kinetics of VEGF from PLG was also measured. RESULTS: PLG-VEGF resulted in improved lower extremity perfusion vs. controls as measured by LDPI% at 7, 14, 21, and 28 days (p < 0.05). PLG-VEGF was associated with significantly greater percentage of vessels staining for CD31 and alpha-smooth muscle actin compared to the Empty-PLG or 0-Implant (p < 0.05 for both). CONCLUSIONS: The PLG-VEGF scaffolds resulted in sustained VEGF delivery, improved tissue perfusion, greater capillary density, and more mature vasculature compared to the controls. The sustained-release PLG polymer vehicle is a promising delivery system for therapeutic neovascularization applications.
PURPOSE: We hypothesized that sustained delivery of vascular endothelial growth factor (VEGF) using a polymer [85:15 poly(lactide-co-glycolide) (PLG)] would enhance angiogenesis and improve perfusion of ischemic tissue. METHODS: C57BL/6J mice (n = 20/group) underwent unilateral hind limb ischemia surgery and were randomized to groups of no scaffold implantation (0-Implant), unloaded scaffold implantation (Empty-PLG), or implantation of scaffolds incorporating 3 microg of VEGF165 (PLG-VEGF). Endpoints included laser Doppler perfusion imaging (LDPI, ischemic/nonischemic limb, %), local vessel counts, immunohistochemistry for CD31, and alpha-smooth muscle actin. In vitro release kinetics of VEGF from PLG was also measured. RESULTS: PLG-VEGF resulted in improved lower extremity perfusion vs. controls as measured by LDPI% at 7, 14, 21, and 28 days (p < 0.05). PLG-VEGF was associated with significantly greater percentage of vessels staining for CD31 and alpha-smooth muscle actin compared to the Empty-PLG or 0-Implant (p < 0.05 for both). CONCLUSIONS: The PLG-VEGF scaffolds resulted in sustained VEGF delivery, improved tissue perfusion, greater capillary density, and more mature vasculature compared to the controls. The sustained-release PLG polymer vehicle is a promising delivery system for therapeutic neovascularization applications.
Authors: M Simons; R O Bonow; N A Chronos; D J Cohen; F J Giordano; H K Hammond; R J Laham; W Li; M Pike; F W Sellke; T J Stegmann; J E Udelson; T K Rosengart Journal: Circulation Date: 2000-09-12 Impact factor: 29.690
Authors: J L Cleland; E T Duenas; A Park; A Daugherty; J Kahn; J Kowalski; A Cuthbertson Journal: J Control Release Date: 2001-05-14 Impact factor: 9.776
Authors: Emile R Mohler; Sanjay Rajagopalan; Jeffrey W Olin; Jeffrey D Trachtenberg; Henrik Rasmussen; Raphael Pak; Ronald G Crystal Journal: Vasc Med Date: 2003 Impact factor: 3.239
Authors: Sanjay Rajagopalan; Emile R Mohler; Robert J Lederman; Farrell O Mendelsohn; Jorge F Saucedo; Corey K Goldman; John Blebea; Jennifer Macko; Paul D Kessler; Henrik S Rasmussen; Brian H Annex Journal: Circulation Date: 2003-09-22 Impact factor: 29.690
Authors: S Takeshita; L Q Pu; L A Stein; A D Sniderman; S Bunting; N Ferrara; J M Isner; J F Symes Journal: Circulation Date: 1994-11 Impact factor: 29.690
Authors: Laura De Laporte; Anne des Rieux; Hannah M Tuinstra; Marina L Zelivyanskaya; Nora M De Clerck; Andrei A Postnov; Véronique Préat; Lonnie D Shea Journal: J Biomed Mater Res A Date: 2011-05-31 Impact factor: 4.396
Authors: William W Yuen; Nan R Du; Chun H Chan; Eduardo A Silva; David J Mooney Journal: Proc Natl Acad Sci U S A Date: 2010-10-04 Impact factor: 11.205
Authors: Edward A Phelps; Natalia Landázuri; Peter M Thulé; W Robert Taylor; Andrés J García Journal: Proc Natl Acad Sci U S A Date: 2009-12-31 Impact factor: 11.205
Authors: Meghan M Nickerson; Ji Song; Casey W Shuptrine; Kristen A Wieghaus; Edward A Botchwey; Richard J Price Journal: J Biomed Mater Res A Date: 2009-11 Impact factor: 4.396